DRUG · Unmapped registry intervention
PPI-1019 (APAN)
Find medicine records ·
Find other trials using this name
Clinical trial
Safety Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer's Disease
NCT00100334
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedSafety Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer's Disease
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1, PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Alzheimer's Diseaseverified · MONDO: Alzheimer disease
Interventions
PPI-1019 (APAN)DRUG
Sponsors & collaborators
PRAECIS Pharmaceuticals Inc.lead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00100334 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.